Clinical Topics & News

Nodular Fasciitis: A Possible Side Effect of Etanercept?

Etanercept is a biologic agent prescribed by dermatologists for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. Although the safety profile of etanercept is well established, it is always important to be vigilant in noting the development of novel side effects associated with biologic agents. We report a case of biopsy-proven nodular fasciitis (NF) that developed in an otherwise healthy man with plaque psoriasis who was undergoing treatment with etanercept.


 

Recommended Reading

Methotrexate Toxicity Induced by Ciprofloxacin Leading to Psoriatic Plaque Ulceration: A Case Report
MDedge Dermatology
Psoriasiform Eruption Associated With Graft-Versus-Host Disease
MDedge Dermatology
Product News: 09 2013
MDedge Dermatology
Psoriasis and Leprosy: A Mystifying Coexistence
MDedge Dermatology
Psoriasis linked to increased heart failure risk
MDedge Dermatology
Ustekinumab approved for psoriatic arthritis
MDedge Dermatology
Limited data support multiple myositis treatment options
MDedge Dermatology
Autoantibodies play role in myositis classification, treatment
MDedge Dermatology
Psoriasis Treatment With Tumor Necrosis Factor Inhibitors
MDedge Dermatology
Palmar-plantar psoriasis? Anti-TNF therapy may be culprit
MDedge Dermatology

Related Articles